Last week I caught a a very interesting webinar from WOMMA on Facebook’s new policy to no longer allow admins of pharma Pages to disable commenting on the content their Page — a very significant change in the highly regulated and scrutinized world of pharma marketing. The presentation covers the ins and outs of this change, which Pages will be affected, pros vs. cons, and predictions of its impact down the road. If you have an interest in pharma and/or health care marketing this is an informative presentation worth checking out during your lunch break.
Facebook and the FDA: Forcing Pharma’s Hand? (Slides + Audio)